Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study.
D000328:Adult; D001479:Basal Ganglia / Q000378:metabolism; D001549:Benzamides / Q000493:pharmacokinetics; D001667:Binding, Competitive; D003287:Contrast Media / Q000493:pharmacokinetics; D003342:Corpus Striatum / Q000378:metabolism*; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D008297:Male; D011759:Pyrrolidines / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D012559:Schizophrenia / Q000378:metabolism*; D012737:Sex Factors; D015899:Tomography, Emission-Computed, Single-Photon
D001549:Benzamides; D003287:Contrast Media; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide